1969•The Journal of Clinical Endocrinology & MetabolismRequires access

Effect of ACTH and Metyrapone on Estriol, 17-Hydroxycorticosteroid, 17-Ketosteroid, Pregnanediol and Pregnanetriol Excretion Late in Pregnancy

Richard Palmer Dickey, James P. Thompson

Open publisher page 17 citations

Abstract

The effect of ACTH and metyrapone administration on excretion of estriol, 17- hydroxycorticosteroid (17-OHCS), 17-ketosteroid (17-KS), pregnanediol (P-diol) and pregnanetriol (P-triol) was determined in 16 women in the last trimester of pregnancy. The response to ACTH and metyrapone, measured as 17- OHCS excretion, was diminished compared to that reported for nonpregnant women, but was approximately the same when either agent was given. This suggests that altered ACTH release is not the cause of this diminished response. Estriol excretion decreased significantly (p <.00l) following ACTH and increased (p<.1) in 10 of 16 following metyrapone. 17-KS and P-triol changes corresponded to those found for estriol rather than to those found for 17-OHCS. This finding suggests that cortisol from the maternal adrenal may inhibit the fetal pituitaryadrenal axis during pregnancy.

About this research paper

What this paper is about

The effect of ACTH and metyrapone administration on excretion of estriol, 17- hydroxycorticosteroid (17-OHCS), 17-ketosteroid (17-KS), pregnanediol (P-diol) and pregnanetriol (P-triol) was determined in 16 women in the last trimester of pregnancy. The response to ACTH and metyrapone, measured as 17- OHCS excretion, was diminished compared to that reported for nonpregnant women, but was approximately the same when either agent was given. This suggests that altered ACTH release is not the cause of this diminished response. Estriol excretion decreased significantly (p <.00l) following ACTH and increased (p<.1) in 10 of 16 following metyrapone. 17-KS and P-triol changes corresponded to those found for estriol rather than to those found for 17-OHCS. This finding suggests that cortisol from the maternal adrenal may inhibit the fetal pituitaryadrenal axis during pregnancy.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The effect of ACTH and metyrapone administration on excretion of estriol, 17- hydroxycorticosteroid (17-OHCS), 17-ketosteroid (17-KS), pregnanediol (P-diol) and pregnanetriol (P-triol) was determined in 16 women in the last trimester of pregnancy. The response to ACTH and metyrapone, measured as 17- OHCS excretion, was diminished compared to that reported for nonpregnant women, but was approximately the same when either agent was given. This suggests that altered ACTH release is not the cause of this diminished response. Estriol excretion decreased significantly (p <.00l) following ACTH and increased (p<.1) in 10 of 16 following metyrapone. 17-KS and P-triol changes corresponded to those found for estriol rather than to those found for 17-OHCS. This finding suggests that cortisol from the maternal adrenal may inhibit the fetal pituitaryadrenal axis during pregnancy.

Key concepts: Pregnanediol, Metyrapone, Estriol, Endocrinology, Internal medicine, Excretion, Pregnancy, Adrenocorticotropic hormone

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of ACTH and Metyrapone on Estriol, 17-Hydroxycorticosteroid, 17-Ketosteroid, Pregnanediol and Pregnanetriol Excretion Late in Pregnancy — Research Paper | ScholarLens